Role of glucagon-like peptide-1 analogues in weight management

Abstract

Obesity is a growing concern in all parts of the world. It carries major health concerns which are in turn translated into financial costs. Alongside patient education and guidance, both surgical and pharmacological methods are being employed to control weight. A major breakthrough in this regard has been introduction of glucagon-like peptide-1 analogues (GLP-1), which have now been approved for use in weight management(1). Key words: weight management, glucagon-like peptide-1 analogues,